Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
NCT00000831Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of lamivudine, stavudine, zidovudine and didanosine in human immunodeficiency virus infection (HIV) (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
lamivudinestavudinezidovudinedidanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000831.